RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b

Journal of Neuroimmunology

Volumn 107, Issue 1, 2000, Pages 100-107

  Iarlori, Carla ^a   Reale, Marcella ^a   Lugaresi, Alessandra ^a   De Luca, Giovanna ^a   Bonanni, Laura ^a   Di Iorio, Angelo ^a   Feliciani, Claudio ^a   Conti, Pio ^a   Gambi, Domenico ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Adherent monocytes; Chemokines; Interferon ; Multiple sclerosis; RANTES; RT PCR

Indexed keywords

INTERFERON BETA SERINE; RANTES;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PHYTOHEMAGGLUTININS; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034632164     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00261-7     Document Type: Article

References (62)

1. Bacon K.B., Premack B.A., Gardner P., Schall T.J. Activation of dual T cell signalling pathways by the chemokine Rantes. Science. 22:(269):1995;1727-1730.
2. Baggiolini M., Dahinden C.A. CC chemokines in allergic inflammation. Immunol. Today. 15:1994;127.
3. Brod S.A., Marshall G.D. Jr., Henninger E.M., Sriram S., Khan M., Wolinsky J.S. Interferon-β1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis. Neurology. 46:1996;1633-1638.
4. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66.
5. Conti P., Theoharides T.C. Monocyte chemotactic protein-1 (MCP-1) is active on mast cells and causes clump formation. Int. J. Immunopathol. Pharmacol. 7:1994;149-152.
6. Conti P., Boucher W., Letourneau R., Feliciani C., Reale M., Barbacane R.C., Vlagopoulos P., Bruneau G., Thibault J., Theoharides T.C. Monocyte chemotactic Protein 1 (MCP-1) provokes mast cell aggregation and [3H]-5HT-release. Immunology. 86:1995;434-440.
7. Conti P., Pang X., Boucher W., Letourneau R., Reale M., Barbacane R.C., Theoharides T.C. Impact of RANTES and MCP-1 chemokines on in vivo mast cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood. 89:1997;4120-4127.
8. Conti P., Pang X., Boucher W., Letourneau R., Reale M., Barbacane R.C., Thibault J., Theoharides T.C. Rantes is a proinflammatory chemokine and chemoattracts mast cells to extravascular sites. J. Pathol. 183:(3):1997;352-358.
9. Conti P., Pang X., Boucher W., Letourneau R., Reale M., Barbacane R.C., Thibault J., Theoharides T.C. Monocyte chemotactic protein-1 is a proinflammatory chemokine in rat skin injection sites and chemoattracts basophilic granular cells. Int. Immunol. 9:1997;1563-1570.
10. Conti P., Reale M., Feliciani C., Frydas S., Placido F.C., Cataldo I., Barbacane R.C. Augmentation of monocyte chemotactic protein-1 (MCP-1) and mRNA transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo. Immunology. 92:1997;300-306.
11. Conti P., Barbacane R.C., Di Gioacchino M., Reale M. Will MCP-1 and RANTES take center stage in inflammatory diseases including asthma? Allergy Asthma Proc. 19:1998;121-123.
12. Conti P., Reale M., Barbacane R.C., Theoharides T.C. Intramuscular injection of hrRANTES causes mast cell recruitment and transcriptional activation of histidine decarboxylase in mice. Lack of effects in genetically mast cell-deficient w/wv mice. FASEB J. 12:1998;1693-1700.
13. Conti P., Reale M., Barbacane R.C.T., Theoharides C. Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. Br. J. Haematol. 103:1998;798-803.
14. Conti P., Feliciani C., Barbacane R.C., Frydas S., Placido F.C., Cataldo I., Reale M. Gene expression and translation of monocyte chemotactic protein-1 in formed granulomatous calcified tissue in vivo. Calcif. Tissue Int. 64:1999;57-62.
15. De Luca G., Reale M., Iarlori C., Lugaresi A., Conti P., Gambi D. Chemokine secretion by mononuclear cells of patients with multiple sclerosis. Eur. J. Neurol. 5:1998;S125. (Abstract).
16. Gambi D., Muraro P.A., Lugaresi A. Advances in the Immunopathogenesis of Multiple Sclerosis. 1999;1-84 Springer, Italy.
17. Glabinski A.R., Tuohy V.K., Ransohoff R.M. Expression of chemokines RANTES, MIP-1 alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation. 5:1998;166-171.
18. Godiska R., Chantry D., Dietsch G., Gray P. Chemokine expression in murine Experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;167-176.
19. Grant G.M., Cobb J.K., Castillo B., Klebe R.J. Regulation of matrix metalloproteinases following cellular transformation. J. Cell. Physiol. 167:1996;177-183.
20. Guo H., Jin Y.X., Ishikawa M., Huang Y.M., van der Meide P.H., Link H., Xiao B.G. Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines. Scand. J. Immunol. 48:1998;502-508.
21. Hartung H.P., Archelos J.J., Zielasek J., Gold R., Koltzenburg M., Reiners K.H., Toyka K.V. Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology. 45:1995;22-32.
22. Hesselgesser J., Horuk R. Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol. 5:1999;13-26.
23. Hohlfeld R., Meinl E., Weber F., Zipp F., Scmidt S., Sotgiu S., Goebels N., Voltz R., Spuler S., Iglesias A., Werkerle H. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology. 45:1995;33-38.
24. Hvas J., McLean C. Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand. J. Immunol. 46:1997;195-203.
25. Jiang H., Williams G.J., Dhib-Jalbut S. The effect of interferon beta-1b on cytokine induced adhesion molecule expression. Neurochem. Int. 30:1997;449-453.
26. Karpus W.J., Lukacs N.W., Mc Rae B.L., Strieter R.M., Kunkel S.L., Miller S.D. An important role for the chemokines macrophage inflammatory protein-1alpha in the pathogenesis of the T cell mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:1995;5003-5010.
27. Kennedy K.J., Strieter R.M., Kunkel S.L., Lukacs N.W., Karpus W.J. Acute and relapsing experimental autoimmune are regulated by differential expression of the CC chemokines inflammatory protein-1alpha and monocyte chemotactic protein-1. J. Neuroimmunol. 92:1998;98-108.
28. Kim J.J., Tsai A., Nottingham L.K., Morrison L., Cunning D.M., Oh J., Lee D.J., Dang K., Dentchev T., Chalian A.A., Agadjanyan M.G., Weiner B.G. Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo. J. Clin. Invest. 103:1999;869-877.
29. Kivisäkk P., Teleshova N., Özenci V., Huang Y., Matusevicius D., Fredrikson S., Söderström M., Link H. No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis. J. Neuroimmunol. 91:1998;108-112.
30. Leppert D., Waubant E., Burk M.R., Oksenberg J.R., Hauser S.L. Interferon beta-1b inhibits gelatinase secretion and in vivo migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann. Neurol. 40:1996;846-853.
31. Lichtinghagen R.T., Seifert A., Kracke S., Marckmann U., Wurster F., Heidenreich J. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis. Neuroimmunology. 99:1999;19-26.
32. Liebler J.M., Kunkel S.L., Burdick M.D., Standiford T.J., Rolfe M.W., Strieter R.M. Production of IL-8 and Monocyte Chemotactic Peptide-1 by peripheral blood monocytes. disparate responses to phytohemoagglutinin and lipopolysaccharide. J. Immunol. 152:1994;241-249.
33. Luster A. Chemokines-chemotactic cytokines that mediate inflammation. New Engl. J. Med. 338:1998;436-445.
34. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T.J., Galanaud P., Emile D. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154:1995;1870-1878.
35. Matsushima K., Oppenheim J.J. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine. 1:1989;2-13.
36. Noronha A., Toscas A., Jensen M.A. Interferon beta augments suppressor cell function in multiple sclerosis. Ann. Neurol. 27:1990;207-210.
37. Noronha A., Toscas A., Jensen M.A. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J. Neuroimmunol. 46:1993;145-153.
38. Oppenheim J.J., Zacharie C.O.C., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene 'Intecrine' cytokine family. Annu. Rev. Immunol. 9:1991;617.
39. Oppenheim J.J., Lloyd A., Taub D., Wang J.M., Murphy B. Attractive properties of chemokines and their receptors. Int. J. Immunopathol. Pharmacol. 7:1994;219-220.
40. Panitch H.S., Folus J.S., Johnson K.P. Recombinant beta interferon inhibits gamma interferon production in multiple sclerosis. Ann. Neurol. 22:1987;139.
41. Porrini A.M., Gambi D., Reder A.T. Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J. Neuroimmunol. 61:1995;27-34.
42. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
43. Ransohoff R.M. Mechanism of inflammation in MS tissue: adhesion molecules and chemokines. J. Neuroimmunol. 98:1999;57-68.
44. Ransohoff R.M., Glabinski A., Tani M. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev. 7:1996;35-46.
45. Reale M., Frydas S., Barbacane R.C., Conti P., Placido F.C., Cataldo I., Anogianakis G., Dimitriadou D., Vacalis D., Trakatellis A. Int. J. Immunopathol. Pharmacol. 9:1994;109-112.
46. Rollins B.J. Chemokines. Blood. 90:1997;909-928.
47. Rudick R.A., Carpenter C.S., Cookrair D.L., Tuohy V.K., Ransohoff R.M. In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta. Neurology. 43:1993;2080-2087.
48. Schall T.J. Biology of the RANTES/SIS cytokine family. Cytokine. 3:1991;165-170.
49. Schall T.J., Bacon K., Toy K.J., Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 374:1990;669-671.
50. Shakir S., Byskosh P.V., Reader A.T. Interferon-β induces interleukin-10 mRNA in mononuclear cells (MNC). Neurology. 44:(Suppl, 2):1994;A211-212.
51. Simpson J.E., Newcombe J., Cuzner M.L., Woodrofe M.N. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 84:1998;238-249.
52. Siveke J.T., Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 160:1998;550-554.
53. Sørensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:1999;807-815.
54. Springer T.A. Traffic signal for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
55. Stinissen P., Raus J., Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit. Rev. Immunol. 17:1997;33-75.
56. Stüve O., Dooley N.P., Uhm J.H., Antel J.P., Williams G., Yong V.W. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann. Neurol. 40:1996;853-863.
57. Stüve O., Chabot S., Jung S.S., Williams G., Yong V.W. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J. Neuroimmunol. 80:1997;38-46.
58. Szabo M.C., Butcher E.C., McIntyre B.W., Schall T.J., Bacon K.B. RANTES stimulation of T lymphocyte adhesion and activation: role for LFA-1 and ICAM-3. Eur. J. Immunol. 27:1997;1061-1068.
59. Tani M., Ransohoff R.M. Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma? Brain Pathol. 4:1994;135-143.
60. Taub D.D., Sayer T.J., Carter C.R., Ortaldo J.R. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:1995;3877-3888.
61. Valente A.J., Graves D.T., Vialle-Valentin C.E., Delgrado R., Schwarz C.J. Purification of a monocyte chemotactic factor secreted by non human primate vascular cells in culture. Biochemistry. 27:1988;4162-4168.
62. Van Otteren G.M., Standifort T.J., Kunkel S.L., Danforth J.M., Burdick M.D., Abruzzo L.V., Strieter R.M. Expression and regulation of macrophage inflammatory protein-1α by murine alveolar and peritoneal macrophages. Am. J. Respir. Cell Mol. Biol. 10:1994;8.